[1] WOODHEAD, Mark. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. European Respiratory Journal. 2002, 20(Supplement 36), 20S-27s.
ISSN 0903-1936. Dostupné z: doi:10.1183/09031936.02.00702002
[2] TORRES, Antoni. Community-acquired pneumonia: Changing paradigms about mortality. Community Acquired Infection. 2014, 1(1). ISSN 2225-6482. Dostupné z:
doi:10.4103/2225-6482.141744
[3] JAIN, Seema, Wesley H. SELF, Richard G. WUNDERINK, et al. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. New England Journal of Medicine.
2015, 373(5), 415-427. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa1500245 [4] KOLEK, Václav, Petr JAKUBEC a Stanislav LOSSE. Diagnostika a léčba komunitní pneumonie – v jednoduchosti je klíč k úspěchu. Vnitřní lékařství. 2017, 63(11), 770-775.
[5] BENEŠ, Jiří, Olga DŽUPOVÁ, Zuzana BLECHOVÁ a Vítězslav KOLEK. Skórovací systémy hodnotící prognózu komunitních pneumonií. Vnitřní Lékařství. 2012, 58(5), 357-364.
[6] TSOUCALAS, Gregory a Markos SGANTZOS. Hippocrates, on the Infection of the Lower Respiratory Tract among the General Population in Ancient Greece. General Medicine: Open Access. 2016, 04(05). ISSN 23275146. Dostupné z: doi:10.4172/2327- 5146.1000272
[7] SZMUK, Peter, Tiberiu EZRI, Shmuel EVRON, Yehudah ROTH a Jeffrey KATZ. A brief history of tracheostomy and tracheal intubation, from the Bronze Age to the Space
Age. Intensive Care Medicine. 2008, 34(2), 222-228. ISSN 0342-4642. Dostupné z:
doi:10.1007/s00134-007-0931-5
[8] HAJAR, Rachel. The Air of History (Part II) Medicine in the Middle Ages. Heart Views.
2012, 13(4). ISSN 1995-705X. Dostupné z: doi:10.4103/1995-705X.105744
[9] BOBEK, Karel. Prudký zánět plic: Kruposní pneumonie. Plzeň: Theodor Mareš, 1947.
[10] ŠTEFAN, Marek. Antibiotika v klinické praxi. Praha: Galén, 2019. ISBN 978-80-7492- 397-5.
[11] ŠIMSA, Jan. Přírodní léčba a domácí lékař. Praha: F. Strnadel, 1941.
60 [12] MACKENZIE, Grant. The definition and classification of pneumonia. Pneumonia.
2016, 8(1). ISSN 2200-6133. Dostupné z: doi:10.1186/s41479-016-0012-z
[13] JAIN Vardhmaan, VASHISHT Rishik, YILMAZ Gizem, et al. Pneumonia Pathology.
[Updated 2022 Apr 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing;
2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK526116/
[14] BLACK, Andrew D. Non-infectious mimics of community-acquired
pneumonia. Pneumonia. 2016, 8(1). ISSN 2200-6133. Dostupné z: doi:10.1186/s41479-016- 0002-1
[15] MUSHER, Daniel M., Ingrid L. ROIG, Guillermo CAZARES, Charles E. STAGER, Nancy LOGAN a Hossam SAFAR. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: Results of a one-year study. Journal of Infection. 2013, 67(1), 11-18. ISSN 01634453. Dostupné z: doi:10.1016/j.jinf.2013.03.003 [16] ALVES DOS SANTOS, José Wellington, Antoni TORRES, Gustavo Trindade MICHEL, Claudius Wladimir Cornelius DE FIGUEIREDO, Jader Nascimento MILETO, Vilson Gentil FOLETTO a Manuela Araújo de Nóbrega CAVALCANTI. Non-infectious and unusual infectious mimics of community-acquired pneumonia. Respiratory Medicine.
2004, 98(6), 488-494. ISSN 09546111. Dostupné z: doi:10.1016/j.rmed.2003.12.006 [17] BEDI, RajinderSingh. Community acquired pneumonia - Typical or atypical ?. Lung India. 2006, 23(3). ISSN 0970-2113. Dostupné z: doi:10.4103/0970-2113.44406
[18] MANDELL, Lionel A., Richard G. WUNDERINK, Antonio ANZUETO, et al.
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases.
2007, 44(Supplement_2), S27-S72. ISSN 1537-6591. Dostupné z: doi:10.1086/511159 [19] METLAY, Joshua P., Grant W. WATERER, Ann C. LONG, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of
America. American Journal of Respiratory and Critical Care Medicine. 2019, 200(7), e45- e67. ISSN 1073-449X. Dostupné z: doi:10.1164/rccm.201908-1581ST
61 [20] RELLO, Jordi. Demographics, guidelines, and clinical experience in severe community- acquired pneumonia. Critical Care. 2008, 12(Suppl 6). ISSN 1364-8535. Dostupné z:
doi:10.1186/cc7025
[21] TORRES, Antoni, Willy E PEETERMANS, Giovanni VIEGI a Francesco BLASI. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax.
2013, 68(11), 1057-1065. ISSN 0040-6376. Dostupné z: doi:10.1136/thoraxjnl-2013-204282
[22] WATERER, Grant W., Lori A. KESSLER a Richard G. WUNDERINK. Medium-Term Survival after Hospitalization with Community-Acquired Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2004, 169(8), 910-914. ISSN 1073-449X. Dostupné z: doi:10.1164/rccm.200310-1448OC
[23] ALMIRALL, J., I. BOLIBAR, M. SERRA-PRAT, et al. New evidence of risk factors for community-acquired pneumonia: a population-based study. European Respiratory Journal.
2008, 31(6), 1274-1284. ISSN 0903-1936. Dostupné z: doi:10.1183/09031936.00095807 [24] RIVERO-CALLE, I., J. PARDO-SECO, P. ALDAZ, et al. Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO- ES-RISK project). BMC Infectious Diseases. 2016, 16(1). ISSN 1471-2334. Dostupné z:
doi:10.1186/s12879-016-1974-4
[25] WELTE, Tobias a Thomas KÖHNLEIN. Global and Local Epidemiology of
Community-Acquired Pneumonia: The Experience of the CAPNETZ Network. Seminars in Respiratory and Critical Care Medicine. 2009, 30(02), 127-135. ISSN 1069-3424. Dostupné z: doi:10.1055/s-0029-1202941
[26] CILLONIZ, C., S. EWIG, E. POLVERINO, M. A. MARCOS, C. ESQUINAS, A.
GABARRUS, J. MENSA a A. TORRES. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax. 2011, 66(4), 340-346. ISSN 0040-6376.
Dostupné z: doi:10.1136/thx.2010.143982
[27] TORRES, Antoni, Catia CILLÓNIZ, Francesco BLASI, James D. CHALMERS, Jacques GAILLAT, Nathalie DARTOIS, Heinz-Josef SCHMITT a Tobias WELTE. Burden of
pneumococcal community-acquired pneumonia in adults across Europe: A literature review. Respiratory Medicine. 2018, 137, 6-13. ISSN 09546111. Dostupné z:
doi:10.1016/j.rmed.2018.02.007
62 [28] ZAR, H J, S A MADHI, S J ASTON a S B GORDON. Pneumonia in low and middle income countries: progress and challenges. Thorax. 2013, 68(11), 1052-1056. ISSN 0040- 6376. Dostupné z: doi:10.1136/thoraxjnl-2013-204247
[29] FREEMAN, Andrew M., LEIGH, Jr. Townes R. Viral Pneumonia. [Updated 2022 Jul 4].
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513286/
[30] LIMPER, Andrew H., Kenneth S. KNOX, George A. SAROSI, et al. An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients. American Journal of Respiratory and Critical Care Medicine.
2011, 183(1), 96-128. ISSN 1073-449X. Dostupné z: doi:10.1164/rccm.2008-740ST [31] Global tuberculosis report 2021. Geneva: World Health Organization; 2021. Licence:
CC BY-NC-SA 3.0 IGO.
[32] NADERI, HamidReza, Fereshte SHEYBANI, Sedigheh Sadat ERFANI, Bezat AMIRI a Mehdi JABBARI NOOGHABI. The mask of acute bacterial pneumonia may disguise the face of tuberculosis. Electronic physician. 2017, 9(3), 3943-3949. ISSN 20085842. Dostupné z:
doi:10.19082/3943
[33] YAHIAOUI, Rachid Y, Casper DJ DEN HEIJER, Evelien ME VAN BIJNEN, et al.
Prevalence and antibiotic resistance of commensal Streptococcus pneumoniae in nine
European countries. Future Microbiology. 2016, 11(6), 737-744. ISSN 1746-0913. Dostupné z: doi:10.2217/fmb-2015-0011
[34] ROCA-OPORTO, Cristina, Tania CEBRERO-CANGUEIRO, María Luisa GIL- MARQUÉS, et al. Prevalence and clinical impact of Streptococcus pneumoniae nasopharyngeal carriage in solid organ transplant recipients. BMC Infectious Diseases.
2019, 19(1). ISSN 1471-2334. Dostupné z: doi:10.1186/s12879-019-4321-8
[35] BROOKS, Lavida R. K. a George I. MIAS. Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention. Frontiers in Immunology. 2018, 9. ISSN 1664-3224. Dostupné z: doi:10.3389/fimmu.2018.01366
[36] SADER, Helio S, Rodrigo E MENDES, Jennifer LE, Gerald DENYS, Robert K FLAMM a Ronald N JONES. Antimicrobial Susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific Region: Results From 20
63 Years of the SENTRY Antimicrobial Surveillance Program (1997–2016). Open Forum
Infectious Diseases. 2019, 6(Supplement_1), S14-S23. ISSN 2328-8957. Dostupné z:
doi:10.1093/ofid/ofy263
[37] ŽEMLIČKOVÁ, Helena. Antibiotická rezistence u původců komunitních infekcí. Pediatrie pro praxi. 2015, 16(5), 296-298.
[38] SHOAR, Saeed a Daniel M. MUSHER. Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia. 2020, 12(1). ISSN 2200-6133. Dostupné z:
doi:10.1186/s41479-020-00074-3
[39] SLACK, Mary P. E. A review of the role of Haemophilus influenzae in community- acquired pneumonia. Pneumonia. 2015, 6(1), 26-43. ISSN 2200-6133. Dostupné z:
doi:10.15172/pneu.2015.6/520
[40] CILLONIZ, Catia, Cristina DOMINEDÒ, Albert GABARRÚS, et al. Methicillin- susceptible staphylococcus aureus in community-acquired pneumonia: Risk factors and outcomes. Journal of Infection. 2021, 82(1), 76-83. ISSN 01634453. Dostupné z:
doi:10.1016/j.jinf.2020.10.032
[41] SELF, Wesley H., Richard G. WUNDERINK, Derek J. WILLIAMS, et al.
Staphylococcus aureus Community-acquired Pneumonia: Prevalence, Clinical Characteristics, and Outcomes. Clinical Infectious Diseases. 2016, 63(3), 300-309. ISSN 1058-4838.
Dostupné z: doi:10.1093/cid/ciw300
[42] RÁJOVÁ, J., R. PANTŮČEK, P. PETRÁŠ, I. VARBANOVOVÁ, I. MAŠLAŇOVÁ a J.
BENEŠ. Necrotizing pneumonia due to clonally diverse Staphylococcus aureus strains producing Panton-Valentine leukocidin: the Czech experience. Epidemiology and Infection.
2016, 144(3), 507-515. ISSN 0950-2688. Dostupné z: doi:10.1017/S0950268815001521 [43] HIRAI, Jun, Takeshi KINJO, Tomomi KOGA, Shusaku HARANAGA, Eiji
MOTONAGA a Jiro FUJITA. Clinical characteristics of community-acquired pneumonia due to Moraxella catarrhalis in adults: a retrospective single-centre study. BMC Infectious
Diseases. 2020, 20(1). ISSN 1471-2334. Dostupné z: doi:10.1186/s12879-020-05564-9 [44] WRIGHT, Paul W., Richard J. WALLACE a Robert SHEPHERD. A descriptive study of 42 cases of Branhamella catarrhalis pneumonia. The American Journal of Medicine.
1990, 88(5), S2-S8. ISSN 00029343. Dostupné z: doi:10.1016/0002-9343(90)90253-A
64 [45] COLLAZOS, J., J. MIGUEL a R. AYARZA. Moraxella catarrhalis bacteremic
pneumonia in adults: Two cases and review of the literature. European Journal of Clinical Microbiology & Infectious Diseases. 1992, 11(3), 237-240. ISSN 0934-9723. Dostupné z:
doi:10.1007/BF02098086
[46] VON BAUM, H., T. WELTE, R. MARRE, N. SUTTORP a S. EWIG. Community- acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors. European Respiratory Journal. 2010, 35(3), 598-615. ISSN 0903- 1936. Dostupné z: doi:10.1183/09031936.00091809
[47] CHAHIN, Abdullah a Steven M. OPAL. Severe Pneumonia Caused by Legionella pneumophila. Infectious Disease Clinics of North America. 2017, 31(1), 111-121. ISSN 08915520. Dostupné z: doi:10.1016/j.idc.2016.10.009
[48] KASHYAP, Surender a Malay SARKAR. Mycoplasma pneumonia: Clinical features and management. Lung India. 2010, 27(2). ISSN 0970-2113. Dostupné z: doi:10.4103/0970- 2113.63611
[49] PULJIZ, I., I. KUZMAN, O. DAKOVIC-RODE, N. SCHÖNWALD a B. MISE.
Chlamydia pneumoniae and Mycoplasma pneumoniae pneumonia: comparison of clinical, epidemiological characteristics and laboratory profiles. Epidemiology and Infection.
2006, 134(3), 548-555. ISSN 0950-2688. Dostupné z: doi:10.1017/S0950268805005522 [50] FUJITA, Jiro a Takeshi KINJO. Where is Chlamydophila pneumoniae
pneumonia?. Respiratory Investigation. 2020, 58(5), 336-343. ISSN 22125345. Dostupné z:
doi:10.1016/j.resinv.2020.06.002
[51] GALVÁN, José María, Olga RAJAS a Javier ASPA. Review of Non-Bacterial Infections in Respiratory Medicine: Viral Pneumonia. Archivos de Bronconeumología. 2015, 51(11), 590-597. ISSN 03002896. Dostupné z: doi:10.1016/j.arbres.2015.02.015
[52] PETERANDERL, Christin, Susanne HEROLD a Carole SCHMOLDT. Human Influenza Virus Infections. Seminars in Respiratory and Critical Care Medicine. 2016, 37(04), 487-500.
ISSN 1069-3424. Dostupné z: doi:10.1055/s-0036-1584801
[53] UYEKI, Timothy M, Henry H BERNSTEIN, John S BRADLEY, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis,
Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal
65 Influenzaa. Clinical Infectious Diseases. 2019, 68(6), e1-e47. ISSN 1058-4838. Dostupné z:
doi:10.1093/cid/ciy866
[54] RITCHIE, Hannah, Edouard MATHIEU, Lucas RODÉS-GUIRAO, et al. Coronavirus Pandemic (COVID-19). Ourworldindata.org [online]. 2020 [citováno 2.10.2022]. Dostupné z: https://ourworldindata.org/coronavirus
[55] BARTOŠ, Hynek, Lenka FABIANOVÁ, Pavel DLOUHÝ a Dušan OSPALÍK. COVID- 19 asociovaná myelitida – kazuistika vzácné komplikace závažné SARS-CoV-2
infekce. Česká a slovenská neurologie a neurochirurgie. 2021, 84/117(4). ISSN 12107859.
Dostupné z: doi:10.48095/cccsnn2021410
[56] BROWN, Jeremy S. Community-acquired pneumonia. Clinical Medicine. 2012, 12(6), 538-543. ISSN 1470-2118. Dostupné z: doi:10.7861/clinmedicine.12-6-538
[57] CORTELLARO, Francesca, Silvia COLOMBO, Daniele COEN a Pier Giorgio DUCA.
Lung ultrasound is an accurate diagnostic tool for the diagnosis of pneumonia in the
emergency department. Emergency Medicine Journal. 2011, 29(1), 19-23. ISSN 1472-0205.
Dostupné z: doi:10.1136/emj.2010.101584
[58] GARNACHO-MONTERO, Jose, Irene BARRERO-GARCÍA, Maria de Gracia
GÓMEZ-PRIETO a Ignacio MARTÍN-LOECHES. Severe community-acquired pneumonia:
current management and future therapeutic alternatives. Expert Review of Anti-infective Therapy. 2018, 16(9), 667-677. ISSN 1478-7210. Dostupné z:
doi:10.1080/14787210.2018.1512403
[59] POSTMA, Douwe F., Cornelis H. VAN WERKHOVEN, Leontine J.R. VAN ELDEN, et al. Antibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults. New England Journal of Medicine. 2015, 372(14), 1312-1323. ISSN 0028-4793. Dostupné z:
doi:10.1056/NEJMoa1406330
[60] MARTI, Christophe, Olivier GROSGURIN, Stephan HARBARTH, et al. Adjunctive Corticotherapy for Community Acquired Pneumonia: A Systematic Review and Meta- Analysis. PLOS ONE. 2015, 10(12). ISSN 1932-6203. Dostupné z:
doi:10.1371/journal.pone.0144032
66 [61] WOODHEAD, Mark, Catherine A WELCH, David A HARRISON, Geoff BELLINGAN a Jon G AYRES. Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database. Critical Care.
2006, 10(Suppl 2). ISSN 13648535. Dostupné z: doi:10.1186/cc4927
[62] CHALMERS, James D., Pallavi MANDAL, Aran SINGANAYAGAM, Ahsan R.
AKRAM, Gourab CHOUDHURY, Philip M. SHORT a Adam T. HILL. Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis. Intensive Care Medicine. 2011, 37(9), 1409-1420. ISSN 0342-4642. Dostupné z: doi:10.1007/s00134-011-2261-x
[63] TORRES, Antoni, James D. CHALMERS, Charles S. DELA CRUZ, Cristina DOMINEDÒ, Marin KOLLEF, Ignacio MARTIN-LOECHES, Michael NIEDERMAN a Richard G. WUNDERINK. Challenges in severe community-acquired pneumonia: a point-of- view review. Intensive Care Medicine. 2019, 45(2), 159-171. ISSN 0342-4642. Dostupné z:
doi:10.1007/s00134-019-05519-y
[64] LIM, W. S., M.M. VAN DER EERDEN, R. LAING, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003, 58(5), 377-382. ISSN 00406376. Dostupné z:
doi:10.1136/thorax.58.5.377
[65] DWYER, Richard, Jonas HEDLUND, Birgitta HENRIQUES-NORMARK a Mats KALIN. Improvement of CRB-65 as a prognostic tool in adult patients with community- acquired pneumonia. BMJ Open Respiratory Research. 2014, 1(1). ISSN 2052-4439.
Dostupné z: doi:10.1136/bmjresp-2014-000038
[66] BUISING, Kirsty L., Karin A. THURSKY, James F. BLACK, Lachlan MACGREGOR, Alan C STREET, Marcus P KENNEDY a Graham V BROWN. Identifying severe
community-acquired pneumonia in the emergency department: A simple clinical prediction tool. Emergency Medicine Australasia. 2007, 19(5), 418-426. ISSN 1742-6731. Dostupné z:
doi:10.1111/j.1742-6723.2007.01003.x
[67] FINE, Michael J., Thomas E. AUBLE, Donald M. YEALY, et al. A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia. New England Journal of Medicine. 1997, 336(4), 243-250. ISSN 0028-4793. Dostupné z:
doi:10.1056/NEJM199701233360402
67 [68] CHARLES, Patrick G. P., Rory WOLFE, Michael WHITBY, et al. SMART‐COP: A Tool for Predicting the Need for Intensive Respiratory or Vasopressor Support in
Community‐Acquired Pneumonia. Clinical Infectious Diseases. 2008, 47(3), 375-384. ISSN 1058-4838. Dostupné z: doi:10.1086/589754
[69] HUAMAN, Moises A., Alicia DIAZ-KUAN, Sara HEGAB, Indira BRAR a Scott KAATZ. CURB-65 and SMRT-CO in the prediction of early transfers to the intensive care unit among patients with community-acquired pneumonia initially admitted to a general ward. Journal of Hospital Medicine. 2011, 6(9), 513-518. ISSN 15535592. Dostupné z:
doi:10.1002/jhm.921
[70] ZHANG, Xiangqun, Bo LIU, Yugeng LIU, Lijuan MA a Hong ZENG. Efficacy of the quick sequential organ failure assessment for predicting clinical outcomes among community- acquired pneumonia patients presenting in the emergency department. BMC Infectious
Diseases. 2020, 20(1). ISSN 1471-2334. Dostupné z: doi:10.1186/s12879-020-05044-0 [71] JIANG, Jianjun, Jin YANG, Yongmei JIN, Jiyu CAO a Youjin LU. Role of qSOFA in predicting mortality of pneumonia. Medicine. 2018, 97(40). ISSN 0025-7974. Dostupné z:
doi:10.1097/MD.0000000000012634
[72] GARCÍA RODRÍGUEZ, Luis Alberto, Ana RUIGÓMEZ, Mari-Ann WALLANDER a Saga JOHANSSON. Acid-suppressive Drugs and Community-acquired
Pneumonia. Epidemiology. 2009, 20(6), 800-806. ISSN 1044-3983. Dostupné z:
doi:10.1097/EDE.0b013e3181b5f27d
[73] KORNUM, J. B., M. NORGAARD, C. DETHLEFSEN, K. M. DUE, R. W. THOMSEN, A. TJONNELAND, H. T. SORENSEN a K. OVERVAD. Obesity and risk of subsequent hospitalisation with pneumonia. European Respiratory Journal. 2010, 36(6), 1330-1336.
ISSN 0903-1936. Dostupné z: doi:10.1183/09031936.00184209
[74] PACHON, J., M. D. PRADOS, F. CAPOTE, J. A. CUELLO, J. GARNACHO a A.
VERANO. Severe Community-acquired Pneumonia: Etiology, Prognosis, and
Treatment. American Review of Respiratory Disease. 1990, 142(2), 369-373. ISSN 0003- 0805. Dostupné z: doi:10.1164/ajrccm/142.2.369
[75] EWIG, Santiago, Mauricio RUIZ, Josep MENSA, Maria Angeles MARCOS, Jose Antonio MARTINEZ, Francisco ARANCIBIA, Michael S. NIEDERMAN a Antoni
68 TORRES. Severe Community-acquired Pneumonia. Assessment of severity criteria. American Journal of Respiratory and Critical Care Medicine. 1998, 158(4), 1102-1108. ISSN 1073- 449X. Dostupné z: doi:10.1164/ajrccm.158.4.9803114
[76] RUIZ, Mauricio, Santiago EWIG, Antoni TORRES, Francisco ARANCIBIA, Francesc MARCO, Josep MENSA, Miguel SANCHEZ a Jose Antonio MARTINEZ. Severe
Community-acquired Pneumonia. Risk factors and follow-up epidemiology. American
Journal of Respiratory and Critical Care Medicine. 1999, 160(3), 923-929. ISSN 1073-449X.
Dostupné z: doi:10.1164/ajrccm.160.3.9901107
[77] MAHENDRA, M., Abhishek NUCHIN, Ranjith KUMAR, S. SHREEDRAR a Padukudru MAHESH. Predictors of Mortality in Patients with Severe COVID-19
Pneumonia—A Retrospective Study. Advances in Respiratory Medicine. 2021, 89(2), 135- 144. ISSN 2543-6031. Dostupné z: doi:10.5603/ARM.a2021.0036
[78] ROSAS, Ivan O., Norbert BRÄU, Michael WATERS, et al. Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia. New England Journal of Medicine. 2021, 384(16), 1503-1516. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2028700
[79] TONIATI, Paola, Simone PIVA, Marco CATTALINI, et al. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmunity Reviews. 2020, 19(7). ISSN 15689972. Dostupné z: doi:10.1016/j.autrev.2020.102568
[80] BEACH, T.G., A. RUSSEL, Sue LI, et al. Increased Risk of Autopsy-Proven Pneumonia with Sex, Season and Neurodegenerative Disease. Preprint. medRxiv.
2021;2021.01.07.21249410. Published 2021 Jan 8. doi:10.1101/2021.01.07.21249410 [81] PAGANIN, F., F. LILIENTHAL, A. BOURDIN, et al. Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. European Respiratory Journal. 2004, 24(5), 779-785. ISSN 0903-1936. Dostupné z:
doi:10.1183/09031936.04.00119503
[82] ALMIRALL, Jordi, Mateu SERRA-PRAT, Ignasi BOLÍBAR a Valentina BALASSO.
Risk Factors for Community-Acquired Pneumonia in Adults: A Systematic Review of Observational Studies. Respiration. 2017, 94(3), 299-311. ISSN 0025-7931. Dostupné z:
doi:10.1159/000479089
69 [83] ELSHAMLY, Mousa, Mohamed O. NOUR a Abdelmaaboud M.M. OMAR. Clinical presentations and outcome of severe community-acquired pneumonia. Egyptian Journal of Chest Diseases and Tuberculosis. 2016, 65(4), 831-839. ISSN 04227638. Dostupné z:
doi:10.1016/j.ejcdt.2016.06.002
[84] YOSHIMOTO, Akihiro, Hiroyuki NAKAMURA, Masaki FUJIMURA a Shinji
NAKAO. Severe Community-acquired Pneumonia in an Intensive Care Unit: Risk Factors for Mortality. Internal Medicine. 2005, 44(7), 710-716. ISSN 0918-2918. Dostupné z:
doi:10.2169/internalmedicine.44.710
[85] Český statistický úřad, 2022 [online]. Sčítání lidu, domů a bytů 2021. [citováno 23.8.2022]. Dostupné z: https://www.czso.cz/csu/scitani2021/vekova-struktura
[86] HAASE, Nicolai, Ronni PLOVSING, Steffen CHRISTENSEN, et al. Characteristics, interventions, and longer term outcomes of COVID‐19 ICU patients in Denmark—A nationwide, observational study. Acta Anaesthesiologica Scandinavica. 2021, 65(1), 68-75.
ISSN 0001-5172. Dostupné z: doi:10.1111/aas.13701
[87] ZHOU, Yutian, Shujin GUO, Ye HE, Qiunan ZUO, Danju LIU, Meng XIAO, Jinxiu FAN a Xiaohui LI. COVID-19 Is Distinct From SARS-CoV-2-Negative Community- Acquired Pneumonia. Frontiers in Cellular and Infection Microbiology. 2020, 10. ISSN 2235-2988. Dostupné z: doi:10.3389/fcimb.2020.00322
[88] ROD, J. E., Oscar OVIEDO-TRESPALACIOS a Javier CORTES-RAMIREZ. A brief- review of the risk factors for covid-19 severity. Revista de Saúde Pública. 2020, 54. ISSN 1518-8787. Dostupné z: doi:10.11606/s1518-8787.2020054002481
[89] GAO, Ya‐dong, Mei DING, Xiang DONG, et al. Risk factors for severe and critically ill COVID‐19 patients: A review. Allergy. 2021, 76(2), 428-455. ISSN 0105-4538. Dostupné z:
doi:10.1111/all.14657
[90] ROZENFELD, Yelena, Jennifer BEAM, Haley MAIER, Whitney HAGGERSON, Karen BOUDREAU, Jamie CARLSON a Rhonda MEDOWS. A model of disparities: risk factors associated with COVID-19 infection. International Journal for Equity in Health. 2020, 19(1).
ISSN 1475-9276. Dostupné z: doi:10.1186/s12939-020-01242-z
70 [91] ZHENG, Zhaohai, Fang PENG, Buyun XU, et al. Risk factors of critical & mortal
COVID-19 cases: A systematic literature review and meta-analysis. Journal of Infection.
2020, 81(2), e16-e25. ISSN 01634453. Dostupné z: doi:10.1016/j.jinf.2020.04.021 [92] MUELLER, Amber L., Maeve S. MCNAMARA a David A. SINCLAIR. Why does COVID-19 disproportionately affect older people?. Aging. 2020, 12(10), 9959-9981. ISSN 1945-4589. Dostupné z: doi:10.18632/aging.103344
[93] HENIG, Oryan a Keith S. KAYE. Bacterial Pneumonia in Older Adults. Infectious Disease Clinics of North America. 2017, 31(4), 689-713. ISSN 08915520. Dostupné z:
doi:10.1016/j.idc.2017.07.015
[94] CILLÓNIZ, Catia, Eva POLVERINO, Santiago EWIG, et al. Impact of Age and Comorbidity on Cause and Outcome in Community-Acquired Pneumonia. Chest.
2013, 144(3), 999-1007. ISSN 00123692. Dostupné z: doi:10.1378/chest.13-0062 [95] RUIZ, Mauricio, Santiago EWIG, Maria Angeles MARCOS, Jose Antonio MARTINEZ, Francisco ARANCIBIA, Josep MENSA a Antoni TORRES. Etiology of Community-Acquired Pneumonia: impact of age, comorbidity, and severity. American
Journal of Respiratory and Critical Care Medicine. 1999, 160(2), 397-405. ISSN 1073-449X.
Dostupné z: doi:10.1164/ajrccm.160.2.9808045
[96] TICONA, Javier H., Victoria M. ZACCONE a Isabel M. MCFARLANE. Community- Acquired Pneumonia: A Focused Review. American Journal of Medical Case Reports.
2021, 9(1), 45-52. ISSN 2374-2151. Dostupné z: doi:10.12691/ajmcr-9-1-12
[97] KAHLON, S., D.T. EURICH, R.S. PADWAL, A. MALHOTRA, J.K. MINHAS- SANDHU, T.J. MARRIE a S.R. MAJUMDAR. Obesity and outcomes in patients
hospitalized with pneumonia. Clinical Microbiology and Infection. 2013, 19(8), 709-716.
ISSN 1198743X. Dostupné z: doi:10.1111/j.1469-0691.2012.04003.x
[98] NIE, Wei, Yi ZHANG, Sun Ha JEE, Keum Ji JUNG, Bing LI a Qingyu XIU. Obesity survival paradox in pneumonia: a meta-analysis. BMC Medicine. 2014, 12(1). ISSN 1741- 7015. Dostupné z: doi:10.1186/1741-7015-12-61
[99] LUO, Xiao, Yeerfan JIAERKEN, Zhujing SHEN, et al. Obese COVID ‐19 patients show more severe pneumonia lesions on CT chest imaging. Diabetes, Obesity and Metabolism.
2021, 23(1), 290-293. ISSN 1462-8902. Dostupné z: doi:10.1111/dom.14194
71 [100] DENG, Linyan, Jiaoyue ZHANG, Mengyuan WANG a Lulu CHEN. Obesity is
associated with severe COVID-19 but not death: a dose−response meta-
analysis. Epidemiology and Infection. 2021, 149. ISSN 0950-2688. Dostupné z:
doi:10.1017/S0950268820003179
[101] BISCARINI, Simona, Marta COLANERI, Serena LUDOVISI, et al. The obesity paradox: Analysis from the SMAtteo COvid-19 REgistry (SMACORE) cohort. Nutrition, Metabolism and Cardiovascular Diseases. 2020, 30(11), 1920-1925. ISSN 09394753.
Dostupné z: doi:10.1016/j.numecd.2020.07.047
[102] CIMRMAN, Štěpán, Kateřina HAŠKOVÁ a Pavel DLOUHÝ. Clinical Outcomes, Therapy Options and Risk Factor Impact Analysis on 1077 Patients Hospitalized for Covid- 19. Open Access Journal of Biomedical Science. 2021, 5(2). ISSN 2690487X. Dostupné z:
doi:10.38125/OAJBS.000359
[103] BASKARAN, Vadsala, Rachael L. MURRAY, Abby HUNTER, Wei Shen LIM, Tricia M. MCKEEVER a Paulo Lee HO. Effect of tobacco smoking on the risk of developing community acquired pneumonia: A systematic review and meta-analysis. PLOS ONE.
2019, 14(7). ISSN 1932-6203. Dostupné z: doi:10.1371/journal.pone.0220204
[104] Macrotrends.net, 2022 [online]. Czech Republic Smoking Rate 2000-2022. [citováno 27.8.2022]. Dostupné z: 'https://www.macrotrends.net/countries/CZE/czech-
republic/smoking-rate-statistics
[105] Macrotrends.net, 2022 [online]. India Smoking Rate 2000-2022. [citováno 27.8.2022].
Dostupné z: 'https://www.macrotrends.net/countries/IND/india/smoking-rate-statistics
[106] MARRIE, Thomas J. a M. Reza SHARIATZADEH. Community-Acquired Pneumonia Requiring Admission to an Intensive Care Unit. Medicine. 2007, 86(2), 103-111. ISSN 0025- 7974. Dostupné z: doi:10.1097/MD.0b013e3180421c16
[107] RASSOULI, Frank, Maximilian BOESCH, Florent BATY, et al. Smartphone-enabled detection of COugh in COvid-19 (COCO) – preliminary analysis of an exploratory,
observational cohort study. M-Health/e-health. European Respiratory Society, 2021, 2021-11- 25, PA3865-. Dostupné z: doi:10.1183/13993003.congress-2021.PA3865
[108] PAHAR, Madhurananda, Marisa KLOPPER, Robin WARREN a Thomas NIESLER.
COVID-19 cough classification using machine learning and global smartphone
72 recordings. Computers in Biology and Medicine. 2021, 135. ISSN 00104825. Dostupné z:
doi:10.1016/j.compbiomed.2021.104572
[109] MALIK, Preeti, Urvish PATEL, Deep MEHTA, Nidhi PATEL, Raveena KELKAR, Muhammad AKRMAH, Janice L GABRILOVE a Henry SACKS. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evidence-Based Medicine. 2021, 26(3), 107-108. ISSN 2515-446X. Dostupné z: doi:10.1136/bmjebm-2020- 111536
[110] CHALMERS, Sarah, Ali KHAWAJA, Patrick M. WIERUSZEWSKI, Ognjen GAJIC a Yewande ODEYEMI. Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: The role of inflammatory biomarkers. World Journal of Critical Care Medicine.
2019, 8(5), 59-71. Dostupné z doi:10.5492/wjccm.v8.i5.59
[111] TORRES, Antoni, Juan SERRA-BATLLES, Antoni FERRER, Patricio JIMÉNEZ, Rosa CELIS, Erik COBO a Robert RODRIGUEZ-ROISIN. Severe Community-acquired Pneumonia: Epidemiology and Prognostic Factors. American Review of Respiratory Disease.
1991, 144(2), 312-318. ISSN 0003-0805. Dostupné z: doi:10.1164/ajrccm/144.2.312
[112] MOINE, Pierre, Jean-Baptiste VERCKEN, Sylvie CHEVRET, Claude CHASTANG a Philippe GAJDOS. Severe Community-Acquired Pneumonia. Chest. 1994, 105(5), 1487- 1495. ISSN 00123692. Dostupné z: doi:10.1378/chest.105.5.1487
[113] Pneu-VUE report, 2016 [online]. A new view into pneumonia among older adults.
[citováno 14.9.2022]. Dostupné z: https://www.ipsos.com/sites/default/files/migrations/en- uk/files/Assets/Docs/Publications/ipsos-healthcare-pneu-vue-report-czech-republic.pdf [114] Ourworldindata.org, 2020 [online]. RITCHIE, H., E. ORTIZ-OSPINA, D. BELTEKIAN, E.
MATHIEU, J. HASSEL, B. MACDONALD, et al. Coronavirus pandemic (COVID-19). [citováno 14.9.2022] Dostupné z: https://ourworldindata.org/covid-vaccinations
[115] European centre for disease prevention and control, 2018 [online]. Seasonal influenza vaccination and antiviral use in EU/EEA Member States – Overview of vaccine
recommendations for 2017–2018 and vaccination coverage rates for 2015–2016 and 2016–
2017 influenza seasons. [citováno 14.9.2022] Dostupné z:
https://www.ecdc.europa.eu/sites/default/files/documents/seasonal-influenza-antiviral-use- 2018.pdf